How Common Is Keratoconus? Prevalence & Demographics

Keratoconus affects roughly 50 to 230 people per 100,000 in the general population, but that range stretches dramatically depending on where you live, your ethnic background, and how the condition is defined and detected. In the United States, the prevalence sits around 54.5 per 100,000, while in parts of the Middle East and Africa the figure can be dozens of times higher. These gaps are not just genetic; they reflect differences in diagnostic technology, screening habits, climate, and even how researchers draw the line between a normal cornea and an early keratoconus case.

What the Global Numbers Actually Look Like

Keratoconus is a condition in which the cornea progressively thins and bulges into a cone-like shape, distorting vision. For decades it was considered rare, with older textbook estimates hovering around 1 in 2,000 people. Modern corneal imaging has pushed those numbers upward. A widely cited global average puts prevalence at about 1.38 per 1,000, but regional studies reveal enormous variation around that midpoint.¹

In the Eastern Mediterranean Region, a meta-analysis found a pooled prevalence of about 4%, well above the global average. Some individual Middle Eastern countries report rates approaching 5% of their population.² Africa may have even higher rates; one meta-analysis placed African prevalence at 7.9%, though study quality and sample sizes varied considerably.³ European and North American estimates tend to cluster in the range of 50 to 230 per 100,000, though screening studies of younger populations sometimes produce much higher figures.

Part of the reason numbers jump around so much is that there is no universally agreed-upon definition of keratoconus for research purposes. A European population study demonstrated that using different diagnostic cutoffs on the same dataset could produce wildly different prevalence figures, from modest to headline-grabbing. The authors concluded that standardizing definitions is essential before cross-country comparisons can mean much.⁴ When you read a prevalence figure for keratoconus, the definition behind it matters as much as the number itself.

Who Gets It and When

Keratoconus typically shows up during the teenage years or early twenties. In one long-term follow-up study, the average age patients reported first noticing symptoms was about 18, though they did not arrive at a clinic until roughly 25 on average.⁵ That gap between symptom onset and diagnosis is a recurring theme in the keratoconus literature and a major reason why screening has become a topic of interest.

Once diagnosed, the cornea tends to steepen most aggressively in younger patients. A meta-analysis of over 11,500 eyes found that younger patients and those with steeper corneas at diagnosis showed the most progression over a year. For every 10-year increase in age at diagnosis, the rate of corneal steepening dropped meaningfully.⁶ This is why catching keratoconus early in life matters so much: the window of fastest progression is also the window where intervention can do the most good. On the encouraging side, the same long-term study that tracked patients over nearly 30 years found that after about two decades, corneal curvature essentially leveled off.⁵

Sex and Gender Patterns

The relationship between sex and keratoconus is more complicated than a single headline can capture. A large nationwide cohort study spanning ten years found that females had a higher incidence than males, with rates of about 7.1 versus 5.6 per 100,000 person-years.⁷ A U.S. claims-database analysis also found moderately higher prevalence in females overall, with the gap especially pronounced among Black women.⁸

In children, the pattern flips dramatically. A study of pediatric keratoconus patients found that boys outnumbered girls nearly four to one. Male patients in that cohort were younger at diagnosis and more likely to present with advanced disease.⁹ Whether this reflects biology, behavior differences like more vigorous eye rubbing in young boys, or referral patterns is still debated. The takeaway is that depending on which age group you examine, keratoconus can look like either a male-dominant or female-dominant condition.

Ethnicity and Race

Racial and ethnic background is one of the strongest predictors of keratoconus risk. A UK study comparing Asian and white patients in the same city found that the incidence in Asian patients was about 25 per 100,000 per year, compared with roughly 3.3 per 100,000 in white patients. Asian patients also presented at a younger age.¹⁰ In the United States, Black patients not only face elevated prevalence but also tend to present with more severe disease. A multicenter analysis found that Black patients had roughly double the odds of visual impairment at their first visit compared with white patients, along with steeper corneas and thinner corneal tissue.¹¹

Whether these disparities are driven by genetic susceptibility, environmental exposures, or delayed access to care is one of the biggest open questions in keratoconus research. The answer is almost certainly all three, in different proportions for different communities. The high prevalence in the Middle East and Africa, for example, likely reflects a combination of genetic factors, high rates of allergic eye disease in hot climates, and limited access to early-stage diagnostic tools.

Why Geography and Climate Seem to Matter

Beyond ethnicity, the physical environment appears to play a role. A systematic review analyzing climate variables across keratoconus prevalence studies found a significant link between lower humidity and higher rates of the condition. Other climate factors like temperature and UV exposure did not reach statistical significance in that analysis.¹²

Dry, dusty environments may promote keratoconus through an indirect route: they increase rates of eye irritation and allergic conjunctivitis, which leads to more eye rubbing. This connects to a broader picture in which mechanical trauma to the cornea seems to be a genuine driver of the disease, not just an association.

Eye Rubbing, Allergies, and Mechanical Damage

The link between eye rubbing and keratoconus is one of the most consistently reported findings in the field. A review of the evidence concluded that rubbing thins the cornea’s cellular structure, with the damage depending on how hard and how often someone rubs.¹³ This is not a minor behavioral footnote. In clinical practice, getting patients to stop rubbing their eyes is considered a frontline intervention.

Allergies feed directly into this cycle. People with ocular allergies rub their eyes more, and a higher proportion of keratoconus patients have elevated allergy markers in their blood compared with the general population.¹⁴ The proposed pathway is that the allergic response releases inflammatory mediators in the eye, and repeated mechanical pressure from rubbing then weakens corneal collagen fibers already made vulnerable by that inflammation.¹⁵ This allergy-rubbing-inflammation loop helps explain why keratoconus clusters in regions with high rates of allergic eye disease and dry climates.

Conditions That Travel with Keratoconus

Several systemic conditions appear more often in people with keratoconus than in the general population. The strongest association is with Down syndrome. A large U.S. healthcare claims analysis found that the odds of keratoconus were more than six times higher in people with Down syndrome.¹⁶ The reasons are thought to include both the genetic architecture of Down syndrome itself and the higher rates of eye rubbing often observed in people with the condition.¹⁷

Asthma is also associated with keratoconus, with about 30% higher odds in that same claims analysis.¹⁶ Obstructive sleep apnea has drawn attention too. Two separate meta-analyses have found that people with sleep apnea face roughly 1.8 to 1.9 times the odds of keratoconus compared with controls.^{18 19} The mechanism behind that link is still unclear, though some researchers suspect that the repeated pressure on the eyes from sleeping face-down (a common position in sleep apnea patients) or the systemic inflammation associated with the condition may contribute. Other associated conditions include connective tissue disorders and mitral valve prolapse, although these are reported less consistently.²⁰

Familial Risk and Genetics

Keratoconus runs in families. First-degree relatives of someone with the condition have a prevalence of roughly 7.7%, which is dramatically higher than the general population rate.¹ Twin studies and family linkage studies have confirmed a genetic component, though keratoconus does not follow a simple single-gene inheritance pattern. Multiple genes appear to contribute, and environmental factors interact with that genetic susceptibility in ways researchers are still working out.²¹

If a parent or sibling has been diagnosed, it is worth mentioning to your eye care provider even if your own vision seems fine. Corneal topography can pick up early signs of the condition well before symptoms appear, and identifying it early opens the door to treatments that can slow or halt progression.

The Hidden Prevalence Problem

A significant number of keratoconus cases go undetected until something forces a close look at the cornea. This is most visible in the laser vision correction pipeline, where candidates undergo detailed corneal mapping as part of the evaluation. In a multicenter Egyptian study of people seeking LASIK, about 6% of candidates turned out to have clinical or subclinical keratoconus and were excluded from surgery. The majority of those cases were subclinical, meaning patients had no idea anything was wrong.²² A Saudi study found subclinical keratoconus in nearly 10% of laser vision correction candidates.²³

These numbers are inflated relative to the general population because people with early corneal irregularities are more likely to develop the kind of refractive errors that send them to a LASIK clinic in the first place. Still, the finding underscores an important point: official prevalence figures based on clinical diagnoses almost certainly undercount the true burden, especially in populations without routine access to corneal imaging.

Children and Adolescents Face a Tougher Course

Pediatric keratoconus tends to be more aggressive than the adult form. Children’s corneas progress faster, and because kids are less likely to notice or report gradual vision changes, the disease is often more advanced by the time it is caught.²⁴ A study tracking pediatric eyes found that about half showed progression within roughly 20 months, with steeper corneas and the presence of allergies being the strongest predictors of worsening.²⁵

This faster timeline has prompted calls for school-based screening programs. A Kenyan study of over 3,000 high school students found keratoconus in 1.7% and suspected keratoconus in an additional 3.8%, prompting the authors to recommend national school screening.²⁶ A New Zealand study reached a similar conclusion.²⁷ Some researchers have even argued for screening in elementary schools, given that the condition can appear before the teenage years.²⁸ No country has yet implemented widespread corneal topography screening for school-aged children, but the evidence base supporting it continues to grow.

Socioeconomic Gaps in Diagnosis and Severity

Even in countries with universal health coverage, socioeconomic factors shape when keratoconus gets caught and how severe it is at diagnosis. An Austrian study found that demographic factors correlated with disease severity despite the country’s publicly funded healthcare system, suggesting that universal insurance alone does not guarantee equitable access to timely specialty care.²⁹

In the United States, where insurance status varies widely, the gaps are more pronounced. Patients on Medicaid tend to present with more advanced disease, which researchers have attributed to lower physician reimbursement rates that reduce the supply of accepting providers, transportation barriers, and lower health literacy around the importance of eye care.³⁰ These are not just academic observations. Later diagnosis generally means fewer treatment options and worse visual outcomes, because the condition has had more time to progress before intervention.

How Treatment Has Changed the Disease Burden

Keratoconus historically led to corneal transplantation in roughly 10 to 20% of patients.³¹ Corneal cross-linking, a procedure that strengthens the cornea by creating new chemical bonds within its collagen structure, has substantially reduced that number. In Canada, the proportion of corneal transplants performed for keratoconus dropped from around 15% before cross-linking became available to about 5.5% afterward.³² In a U.S. study of patients fitted with scleral contact lenses, only about 3% of eyes went on to need a transplant.³³

This shift has real demographic implications. Because younger and more severe cases progress fastest, early cross-linking can halt the disease during the very window when it would otherwise do the most damage. The declining transplant rate also feeds back into how we think about prevalence: as detection improves and treatment prevents the worst outcomes, more people live with managed keratoconus rather than progressing to transplant or severe visual loss. The disease becomes more common in the statistics partly because it is being caught and catalogued rather than missed.

Quality of Life and Daily Function

Because keratoconus typically strikes during the school and early-career years, its effects on daily life can be disproportionate to what a clinical severity score might suggest. A cross-sectional study of quality-of-life measures found that keratoconus affects near vision, driving ability, daily work performance, and mental health related to social functioning.³⁴ Most patients do not rate their overall health as poor, largely because they are young and otherwise healthy, but the vision-specific burdens are real and measurable.

For people in occupations that demand sharp vision or who live in areas where driving is essential, even moderate keratoconus can reshape daily routines. Contact lens fitting becomes a recurring process as the corneal shape changes, and the lenses required are often specialty designs that cost more and take longer to obtain than standard soft lenses. These practical realities are part of why demographic factors like income and insurance status end up influencing outcomes beyond just the biology of the disease itself.

A Condition That Was Medical History Before It Was Common Knowledge

Keratoconus has been described in medical literature for well over 200 years, though under a bewildering array of names: sugar loaf cornea, cornea conica, staphyloma pellucidum, and many others. John Nottingham’s 1854 treatise is usually credited as the first clear definition, but scattered observations go back to the early 1700s.³⁵ For most of that history, diagnosis required the cornea to be visibly cone-shaped on examination, which only happens in advanced cases. The revolution in corneal topography and tomography over the past few decades has revealed a much larger population of people with early or subclinical disease who would have gone entirely undetected a generation ago. The perceived rarity of keratoconus in older literature says as much about the tools available at the time as it does about the actual frequency of the condition.